ANAPTYSBIO, INC Net Cash Provided by (Used in) Financing Activities in USD from 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Anaptysbio, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to Q1 2025.
  • Anaptysbio, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$28.6M, a 110% decline year-over-year.
  • Anaptysbio, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $127M.
  • Anaptysbio, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$59.3M, a 235% decline from 2022.
  • Anaptysbio, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $44M, a 82.6% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

ANAPTYSBIO, INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$28.6M -$15M -110% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 -$13.6M +$23.9M +63.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 -$37.6M -$42.2M -915% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $4.61M +$4.44M +2660% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $167K +$1.51M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$1.34M -$38K -2.92% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 -$1.3M +$82K +5.93% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$1.38M -$82.1M -102% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $80.7M +$81M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$275K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12

ANAPTYSBIO, INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $127M +$186M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$59.3M -$103M -235% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $44M -$208M -82.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $252M +$253M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 -$879K +$3.61M +80.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$4.49M -$228M -102% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
2018 $223M -$69.1M -23.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $292M +$284M +3290% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $8.63M -$30.8M -78.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $39.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.